These data further establish GSK3β and the GSK3β signaling pathway as potential therapeutic targets in the treatment and prevention of autonomic dysfunction in diabetic patients and establish the GSK3β knockout mouse as an important tool in the study of the pathogenesis and treatment of diabetic autonomic neuropathy. Here, GSK3B is linked to diabetic autonomic neuropathy.